Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Gupta personally monitors each of our patients to ensure safe and effective use
W., McDermott, B
A Dual-Agonist Overview Tirzepatide is a synthetic peptide that acts as a dual agonist of the GLP-1 and GIP receptors
Triple-receptor agonist, GLP-1, GIP, and glucagon pathways Extended half-life for stable pharmacokinetic profiles Subject of multiple ongoing clinical trials Pre-filled pen for precise, repeatable delivery Janoshik-verified, 99% purity guaranteed What Researchers Say Frequently Asked Questions Retatrutide (LY3437943) is an investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon receptors
That familiar approach works at first, but as dosing, diet, and activity change, correlations fragment, and you spend clinic time recounting fragmented details
US$ 26.88
US$ 25.95
US$ 29.11
